MetaCap

Serina Therapeutics (SER) vs Zhengye Biotechnology (ZYBT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Zhengye Biotechnology (ZYBT) has outperformed Serina Therapeutics (SER) over the past year, losing 60.5% versus a loss of 62.8%. Zhengye Biotechnology is the larger company by market cap ($55.0 million vs $51.1 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SER-62.78%ZYBT-60.54%
+185%+47%-91%
Oct 7, 20251 yearOct 7, 2026
SER-57.77%ZYBT-74.87%
+206%+53%-100%
Jan 6, 20255 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SER versus ZYBT key metrics
MetricSERZYBT
Share price$2.01$1.16
Market cap$51.05M$54.97M
1-day change-1.47%+4.50%
YTD return+5.07%+0.87%
1-year return-62.78%-60.54%
5-year return-93.88%—
EPS (TTM)$-1.87$-0.21
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$5.83$8.01
52-week low$1.22$0.616
Distance from 52-week high-65.52%-85.52%
Average volume64.24K5.19M
Shares outstanding25.40M47.39M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

SER vs ZYBT FAQ

Which is bigger, Serina Therapeutics or Zhengye Biotechnology?

Zhengye Biotechnology (ZYBT) is larger, with a market capitalization of $54.97M compared with $51.05M for Serina Therapeutics (SER).

Which stock has performed better over the past year, SER or ZYBT?

ZYBT returned -60.54% over the past 12 months, compared with -62.78% for SER (price return, excluding dividends). Past performance does not predict future results.

Are Serina Therapeutics and Zhengye Biotechnology in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons